News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Research>HSBC Research Raises XPENG-W (09868.HK) TP to $107, Expects Strong Sales Momentum to Continue
XPENG-W (09868.HK) (XPEV.US) outperformed its EV peers in April with sales of about 35,000 units, up 6% MoM and 237% YoY, HSBC Global Research issued a research report saying. The ...
Reset
Send
The window will close in 5 seconds
<Research>HSBC Research Raises XPENG-W (09868.HK) TP to $107, Expects Strong Sales Momentum to Continue
Close
Recommend
4
Positive
17
Negative
6
 
 

XPENG-W (09868.HK)  +2.300 (+2.921%)    Short selling $70.44M; Ratio 8.989%   (XPEV.US)      outperformed its EV peers in April with sales of about 35,000 units, up 6% MoM and 237% YoY, HSBC Global Research issued a research report saying.

The broker forecasted the strong sales momentum to continue, driven by sales expansion of the G6, G9 and X9, as well as the launch of a new SUV model, the G7, and new models with extended ranges coming in the next few quarters.

Related NewsBOCOMI: Positive Improvement Expected in Int'l/ Domestic Mkts w/ Positive Catalyst for HK Stocks; Focus on 3 Main Lines Suggested
HSBC Global Research raised its target price for XPENG-W's H-shares/ US stock to $107/ US$27.4 from $101/ US$25.9, with rating kept at Buy.

The broker left its 2025 earnings forecast broadly unchanged, and lifted its 2026 earnings forecast by 25% on higher margin outlook, benefiting from economies of scale under higher sales volume anticipations.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-14 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)

AAStocks Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.